+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celldex Therapeutics, Inc.  - logo

Celldex Therapeutics is a biopharmaceutical company that develops, manufactures, and commercializes novel therapeutics for human health care. The company's pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines. The company's lead drug candidates are Rintega, Glembatumumab vedotin, Varlilumab and others. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex. It is now headquartered in Hampton, New Jersey.

From
From
From
From
From
From
Vaccine Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Vaccine Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 400 Pages
  • Global
From
From
From
From
Cancer Vaccines: Technologies and Global Markets 2021-2026 - Product Thumbnail Image

Cancer Vaccines: Technologies and Global Markets 2021-2026

  • Report
  • July 2021
  • 155 Pages
  • Global
From
Cancer Vaccines Global Market Report 2024 - Product Thumbnail Image

Cancer Vaccines Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Metastatic Renal Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Renal Cell Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 170 Pages
  • Global
From
Pancreatic Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 260 Pages
  • Global
From
Loading Indicator